Clinical Trials Logo

Burns clinical trials

View clinical trials related to Burns.

Filter by:

NCT ID: NCT00324311 Completed - Burn Clinical Trials

Enzymatic Debridement in Burns Patients: A Comparison to Standard of Care

Start date: December 2005
Phase: Phase 3
Study type: Interventional

Burns represent one of the most severe and dreaded traumas. Burned and traumatized tissue is known as eschar. The dead eschar, if not removed, often becomes heavily contaminated and is the source of local and/or systemic infection or sepsis. The local inflammation and infection destroy healthy surrounding tissues and extends the original damage. In order to prevent these complications, and in order to minimize the risk of infection, it is imperative to evaluate the burn and remove all of the offending eschar at the earliest possible opportunity. This removal of dead tissue is termed "debridement". The most direct debridement method for eschar removal is surgery. Traditional, conservative non-surgical debridement is a lengthy process which often involves many complications. The objective of this study is to evaluate the safety and enzymatic debriding efficacy of Debrase Gel Dressing (DGD) in hospitalized patients with deep partial thickness and/or full thickness thermal burns and to compare DGD to standard of care (SOC).

NCT ID: NCT00297752 Completed - Burns Clinical Trials

Treatment of Facial Burns With Flammacerium Compared to Flammazine and the Impact of Facial Burns on Psychosocial Wellbeing

Start date: March 2006
Phase: Phase 4
Study type: Interventional

The face is involved in 40-50% of patients with burns admitted to the Dutch Burn Centres. Scarring of the face as a consequence of burns will often have a detrimental effect on function and aesthetics, and may cause negative effects on psychosocial wellbeing. What the best treatment is for facial burns, minimising scarring, is unclear. Besides that, there is little empirical evidence regarding the impact of facial scarring on psychosocial wellbeing. In clinical practice good results are felt to be achieved by treatment of facial burns with flammacerium. To substantiate the perceived advantages of flammacerium, its efficacy is compared to flammazine, a current alternative of care. The efficacy of treatment will be assessed in a prospective randomised multicentre clinical trial. Efficacy will be analysed in terms of number of patients requiring surgery and functional and aesthetic outcome. Apart from medical outcome, this study offers the opportunity to study psychosocial problems associated with facial defects. It is still an unresolved question whether facial scarring causes more or different psychosocial problems. Therefore, self-esteem and quality of life will be examined over time, in relation to depression, posttraumatic stress symptoms and other factors, such as coping style and social support. By evaluating the efficacy of different treatment strategies, we aim to optimise the standard of care of facial burns. Furthermore, this study wants to shed more light on the psychosocial impact of facial injury. With these results psychosocial professionals will be able to focus on persons at risk and to be better able to meet a patient's personal needs.

NCT ID: NCT00285636 Completed - Burn Clinical Trials

Long Term Follow-Up of Burn Injuries

Start date: June 1992
Phase: N/A
Study type: Observational

The purpose of the study is to investigate the psychological effects of burn injuries as experienced by patients.

NCT ID: NCT00261690 Completed - Burn Clinical Trials

Virtual Reality Pain Control During Burn Wound Care

VRPT/H2O/RT
Start date: February 2002
Phase: Phase 2/Phase 3
Study type: Interventional

Using Virtual Reality as a form of Distraction during Burn Care.

NCT ID: NCT00257244 Completed - Trauma Clinical Trials

Inflammation and the Host Response to Injury (Burns)

Start date: April 2004
Phase:
Study type: Observational

The purpose of this study is to help improve our understanding of the biology involved in the body's response to serious trauma or burn injury. The host response to trauma and burns is a collection of physiological and pathophysiological processes that depend critically upon the regulation of the human innate immune system, with particular emphasis on the inflammatory component of that system. No single research center or small group of centers has the capacity to delineate the integrated response of this complex biological system, which involves multiple molecular and genetic interactions that vary in time. Our proposal promotes the identification of important dynamic relationships that regulate the integration of this complex biological system, with the expectation that this understanding will ultimately impact the diagnosis, prognosis, and treatment of the hospitalized, severely injured patient.

NCT ID: NCT00257231 Completed - Trauma Clinical Trials

Inflammation and the Host Response to Injury (Trauma)

Start date: November 2003
Phase:
Study type: Observational

The purpose of this study is to help improve our understanding of the biology involved in the body's response to serious trauma or burn injury. The host response to trauma and burns is a collection of physiological and pathophysiological processes that depend critically upon the regulation of the human innate immune system, with particular emphasis on the inflammatory component of that system. No single research center or small group of centers has the capacity to delineate the integrated response of this complex biological system, which involves multiple molecular and genetic interactions that vary in time. Our proposal promotes the identification of important dynamic relationships that regulate the integration of this complex biological system, with the expectation that this understanding will ultimately impact the diagnosis, prognosis, and treatment of the hospitalized, severely injured patient.

NCT ID: NCT00255996 Completed - Burns Clinical Trials

Evaluation Of Linezolid Pk Profile In Burns Patients

Start date: May 2006
Phase: Phase 1
Study type: Interventional

Evaluation of linezolid pk profile in burns patients

NCT ID: NCT00243243 Completed - Burns Clinical Trials

Effect of rFVIIa on Peri-operative Blood Loss in Patients Undergoing Major Burn

Start date: January 2006
Phase: Phase 3
Study type: Interventional

The purpose of the study is to see if a medication (Recombinant Coagulation Factor VIIa or NovoSeven), normally used to stop bleeding in persons with a bleeding disorder, will lower the amount of blood lost during burn surgery.

NCT ID: NCT00242970 Completed - Burn Clinical Trials

Hypertrophic Scarring After Facial Burn

Start date: October 2005
Phase: Phase 2
Study type: Observational

Subjects with a burn to the face and/or neck will be enrolled into the study and a Three-Dimensional scanner used to see if it can objectively measure scar color and volume and measure the effect of scar on motion of the face and neck.

NCT ID: NCT00239668 Completed - Burn Clinical Trials

Multicenter Benchmarking of Functional and Psychosocial Outcomes of Pediatric Burn Survivors

Start date: March 2000
Phase:
Study type: Observational

The purpose of this study is to establish an expected recovery trajectory (recovery model) in terms of physical and psychological function of the pediatric burn patient.